BIO Elects John Maraganore, Ph.D., as New Chair

SAN DIEGO–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) is pleased to announce the election of John Maraganore, Ph.D., Chief Executive Officer, Alnylam Pharmaceuticals, Inc., as the new Chair of its Board of Directors for the 2017-2018 term, and the election of Julie Gerberding, Executive Vice President for Strategic Communications, Global Public Policy & Population Health & Chief Patient Officer, Merck, as its new Board Secretary. BIO also is pleased to announce the
Source: BusinessWire-Primary

BIO Elects John Maraganore, Ph.D., as New Chair